SCHEMBL13362091

SCHEMBL13362091

COc1cc(N2CC3CN(CC(=O)N(C)C)CC(C2)O3)ccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.39
INSR P06213 2/20 0.39
ALK Q9UM73 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GAK O14976 1/20 0.36
IGF1R P08069 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR4 Q13639 4/20 0.35
LGMN Q99538 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR1D P28221 1/20 0.34
ADRA1B P35368 1/20 0.34
HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13362089 0.83 MAPT (0.46) KCNH2INSRALKCYP3A4CYP2C9
SCHEMBL3313268 0.82 IGF1R (0.47) KCNH2ALKCYP3A4GAKIGF1R
SCHEMBL13362048 0.82 CCR1 (0.36) KCNH2CYP2C19GAKMEN1KMT2A
SCHEMBL3345793 0.81 GAK (0.38) KCNH2CYP3A4GAKIGF1RHTR4
SCHEMBL3314196 0.81 GAK (0.39) ALKCYP3A4GAKBRD4
SCHEMBL13362105 0.80 SMN1; SMN2 (0.42) KCNH2IGF1RMEN1KMT2AHTR4
SCHEMBL13362043 0.80 ALK (0.38) KCNH2ALKCYP3A4GAKIGF1R
SCHEMBL13362030 0.80 IGF1R (0.42) KCNH2CYP3A4GAKIGF1RHTR4
SCHEMBL13362088 0.80 GAK (0.37) KCNH2GAKIGF1RKMT2AHTR4
SCHEMBL13362038 0.80 ALK (0.40) ALKGAKKMT2AHTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010049731-A1 PYRAZOLO- AND IMIDAZOPYRIDINYLPYRIMIDINEAMINES AS IGF-1R TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2010-05-06 WO disclosed